Log in or Sign up for Free to view tailored content for your specialty!
Substance Use Disorders News
Impaired driving in older adults acute 30 minutes after cannabis ingestion
In a cohort of older adults who smoked cannabis, impaired driving and elevated blood THC levels were significant 30 minutes after ingestion, according to research from JAMA Network Open.
Reducing drug use improves clinical outcomes in patients with stimulant use disorder
Reduced drug use was linked to lower levels of craving, depression and other drug-related problems among individuals with stimulant use disorder, even if they did not achieve abstinence, according to a study published in Addiction.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: US experiencing ‘very concerning’ rise in overdose deaths among adolescents
Overdose deaths among high school-aged adolescents in the United States more than doubled between 2019 and 2020, researchers reported this week in The New England Journal of Medicine found.
Study: Residential addiction treatment for adolescents limited, costly
Residential addiction treatment centers serving adolescents are scarce and expensive in the United States, new study findings suggest, despite increasing overdose rates among young people in recent years.
Syringes used by PWID contained chemical, biological contaminants
An analysis of syringe residue from discarded drug use equipment used by people who inject showed both chemical and biological contaminants in the syringes.
Top psych stories of 2023: Physician burnout, ‘transformative’ psychedelics, more
Some of the most-viewed stories on Healio Psychiatry over the past year highlighted the FDA designating an at-home depression treatment as a breakthrough device as well as the transformative power of psychedelics.
New studies highlight changing trends in substance use, treatment among children
Below is a list of stories involving substance use and children that were published by Healio in 2023.
FDA approves DNA test to assess risk for developing opioid use disorder
The FDA has approved AvertD, the first DNA test to identify an elevated risk for developing opioid use disorder, according to a press release.
NIH awards Delix $320K to advance neuroplastogen for substance use disorders
Delix Therapeutics announced it has received a $320,000 grant from NIH’s National Institute on Drug Abuse to advance its novel, non-hallucinogenic neuroplastogen for treatment of substance use disorders, including opioid and stimulant use.
Survey: More US teens abstaining from drugs, alcohol
More than 60% of 12th graders who responded to a yearly survey of junior high and high school students reported not using alcohol, cannabis or nicotine in the past 30 days — the highest level of abstention in the survey’s history.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read